Clinical Trial Management Systems (CTMS)

Clinical Trial Management Systems (CTMS)

Global Cloud Computing Services Market to Reach $937.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Cloud Computing Services estimated at US$313.1 Billion in the year 2020, is projected to reach a revised size of US$937.5 Billion by 2027, growing at a CAGR of 17% over the analysis period 2020-2027. Infrastructure as a Service, one of the segments analyzed in the report, is projected to record a 18.4% CAGR and reach US$449.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Platform as a Service segment is readjusted to a revised 16.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $84.2 Billion, While China is Forecast to Grow at 22.2% CAGR

The Cloud Computing Services market in the U.S. is estimated at US$84.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$222.5 Billion by the year 2027 trailing a CAGR of 22.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 15.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.

Software as a Service Segment to Record 15.1% CAGR

In the global Software as a Service segment, USA, Canada, Japan, China and Europe will drive the 14.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$57.7 Billion in the year 2020 will reach a projected size of US$145.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$145.6 Billion by the year 2027, while Latin America will expand at a 16.8% CAGR through the analysis period.

Select Competitors (Total 224 Featured) -

  • Acquia Inc.
  • Adobe Inc.
  • Akamai Technologies, Inc.
  • Alibaba Cloud
  • Amazon Web Services, Inc.
  • CA Technologies, Inc.
  • Dell Inc.
  • ENKI Corporation
  • Fujitsu Limited
  • Google, Inc.
  • Hewlett-Packard Development Company, L.P.
  • IBM Corp.
  • Microsoft Corp.
  • NTT DATA Corporation
  • Oracle Corporation
  • OVH
  • Salesforce.com, Inc.
  • SAP SE
  • ServiceNow, Inc.
  • Virtustream, Inc.
  • Workday Inc.
  • Zoho Corporation Pvt. Ltd.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Clinical Trial Management Systems (CTMS) Gain Ground
Recent Market Activity
Benefits Offered by CTMS
Global Market Overview
Clinical Trial Management Systems Market to Post Explosive Growth
Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
Key Players in the CTMS Market
Developed Countries Rule the Market
Pharmaceutical Firms and CROs to Drive Adoption Rate
Noteworthy Transformations in the Global Clinical Trial Sector
2. FOCUS ON SELECT PLAYERS
ArisGlobal, LLC (USA)
BioClinica, Inc. (USA)
Bio-Optronics, Inc. (USA)
DSG, Inc. (USA)
eResearch Technology, Inc. (USA)
IBM Watson Health (USA)
MedNet Solutions (USA)
Medidata Solutions (USA)
Nextrials, Inc. (USA)
Oracle Corp. (USA)
PAREXEL International Corp. (USA)
Trial By Fire Solutions, LLC (USA)
Veeva Systems, Inc. (USA)
Winchester Business Systems (USA)
3. MARKET TRENDS & DRIVERS
Surging Global Population Offers Increased Growth Opportunities
Increased Spend on R&D - An Important Growth Driver
CROs - The Targeted Customers for CTMS
Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
CROs Adept with New Technologies to See More Business in Future
Rise in Clinical Trial Complexities Propels CTMS Demand
Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
Adoption of Digital Technologies Gains Pace
Clinical Trial Operators Demand Efficient Data Management Platforms
DLB System’s Solution with Data Management Tools
Systems Integration Becomes Imperative
Technological Innovations Drive Market Growth
MC10 Introduces BioStampRC System to Capture Clinical Trial Data
UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Enterprise CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Enterprise CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Enterprise CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Web-based (Hosted) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Web-based (Hosted) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Web-based (Hosted) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Cloud-based (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Cloud-based (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Cloud-based (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Pharmaceutical & Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Pharmaceutical & Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Pharmaceutical & Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 31: USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 34: USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 37: USA Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: USA Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 40: Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 43: Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 46: Canada Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Canada Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 49: Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 52: Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 55: Japan Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Japan Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 58: China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 61: China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: China Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 64: China Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: China Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
TABLE 67: Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 70: Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 73: Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 76: Europe Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 79: France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 82: France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: France Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 85: France Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: France Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 88: Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 91: Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Germany Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) for the Years 2012, 2020 & 2027
TABLE 94: Germany Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Germany Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical, Contract Research Organizations, Medical Devices and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
TABLE 97: Italy Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Clinical Trial Management Systems (CTMS) by Type - Enterprise CTMS and Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Type - Percentage Breakdown of Value Sales for Enterprise CTMS and Site CTMS for the Years 2012, 2020 & 2027
TABLE 100: Italy Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-based (Hosted), Licensed Enterprise (On-Premise) and Cloud-based (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook